Biotech companies in the United States by one-year price change
How far the share price has moved over the last 52 weeks.
Moderna leads the 20 biotech companies in the United States ranked by one-year price change, at +740%, ahead of Kodiak Sciences (+371%) and Twist Bioscience (+291%). Figures as of 20 Nov 2026, 11:51 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 20
- First
- Moderna+740%
- Median
- +46.5%
- Combined market value
- THB 24.92T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Biotech▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ModernaMRNA · Health Care | +740% | THB 2.73T | THB 6,759.28 | 1.29% up | 740% up | ||
| 2 | Kodiak SciencesKOD · Health Care | +371% | THB 217.1B | THB 3,319.79 | 0.09% up | 371% up | ||
| 3 | Twist BioscienceTWST · Health Care | +291% | THB 258.1B | THB 3,785.03 | 4.07% down | 291% up | ||
| 4 | ImmunityBioIBRX · Health Care | +216% | THB 237B | THB 222.79 | 1.94% down | 216% up | ||
| 5 | Revolution MedicinesRVMD · Health Care | +125% | THB 1.17T | THB 5,406.27 | 0.24% down | 125% up | ||
| 6 | CG OncologyCGON · Health Care | +93.0% | THB 248.1B | THB 2,777.23 | 2.38% up | 93% up | ||
| 7 | Kymera TherapeuticsKYMR · Health Care | +80.8% | THB 345.6B | THB 4,048.51 | 1.44% down | 81% up | ||
| 8 | ExelixisEXEL · Health Care | +54.9% | THB 544.7B | THB 2,232.30 | 3.60% down | 55% up | ||
| 9 | Adaptive BiotechnologiesADPT · Health Care | +50.7% | THB 154B | THB 951.18 | 1.44% down | 51% up | ||
| 10 | Krystal BiotechKRYS · Health Care | +49.0% | THB 317.4B | THB 10,709.46 | 0.15% up | 49% up | ||
| 11 | ImmunovantIMVT · Health Care | +44.0% | THB 228.2B | THB 1,102.75 | 1.96% down | 44% up | ||
| 12 | BiogenBIIB · Health Care | +41.0% | THB 1.24T | THB 8,380.18 | 1.70% down | 41% up | ||
| 13 | Halozyme TherapeuticsHALO · Health Care | +32.3% | THB 359.7B | THB 3,154.99 | 2.88% down | 32% up | ||
| 14 | Gilead SciencesGILD · Health Care | +31.5% | THB 7T | THB 5,647.03 | 1.45% down | 31% up | ||
| 15 | AmgenAMGN · Health Care | +30.0% | THB 8.05T | THB 14,880.39 | 1.14% down | 30% up | ||
| 16 | Scholar Rock HoldingSRRK · Health Care | +25.3% | THB 208.4B | THB 1,708.05 | 4.94% up | 25% up | ||
| 17 | VaxcytePCVX · Health Care | +22.1% | THB 313.3B | THB 1,978.99 | 0.27% down | 22% up | ||
| 18 | Bio-TechneTECH · Health Care | +18.2% | THB 387.3B | THB 2,465.26 | 0.07% down | 18% up | ||
| 19 | Neurocrine BiosciencesNBIX · Health Care | +10.4% | THB 537.5B | THB 5,309.97 | 3.85% down | 10% up | ||
| 20 | RepligenRGEN · Health Care | +4.79% | THB 369.1B | THB 5,774.53 | 1.38% down | 5% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 33.9100 THB).
Questions and answers
Which biotech companies in the United States rank first by one-year price change?
Moderna (+740%), Kodiak Sciences (+371%) and Twist Bioscience (+291%) are the top three of the 20 biotech companies in the United States ranked by one-year price change as of 20 Nov 2026, 11:51 UTC.
How many biotech companies in the United States are in this ranking?
20 are ranked by one-year price change.
What are these biotech companies in the United States worth together?
The 20 biotech companies in the United States ranked by one-year price change have a combined market value of THB 24.92T as of 20 Nov 2026, 11:51 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Biotech companies in the United States by one-year price change”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.